285 related articles for article (PubMed ID: 17570134)
1. COMP mutations: domain-dependent relationship between abnormal chondrocyte trafficking and clinical PSACH and MED phenotypes.
Chen TL; Posey KL; Hecht JT; Vertel BM
J Cell Biochem; 2008 Feb; 103(3):778-87. PubMed ID: 17570134
[TBL] [Abstract][Full Text] [Related]
2. Cell-type specific trafficking of expressed mutant COMP in a cell culture model for PSACH.
Chen TL; Stevens JW; Cole WG; Hecht JT; Vertel BM
Matrix Biol; 2004 Nov; 23(7):433-44. PubMed ID: 15579310
[TBL] [Abstract][Full Text] [Related]
3. Expression of mutant cartilage oligomeric matrix protein in human chondrocytes induces the pseudoachondroplasia phenotype.
Merritt TM; Alcorn JL; Haynes R; Hecht JT
J Orthop Res; 2006 Apr; 24(4):700-7. PubMed ID: 16514635
[TBL] [Abstract][Full Text] [Related]
4. COMP mutations, chondrocyte function and cartilage matrix.
Hecht JT; Hayes E; Haynes R; Cole WG
Matrix Biol; 2005 Jan; 23(8):525-33. PubMed ID: 15694129
[TBL] [Abstract][Full Text] [Related]
5. Chondrocyte cell death and intracellular distribution of COMP and type IX collagen in the pseudoachondroplasia growth plate.
Hecht JT; Makitie O; Hayes E; Haynes R; Susic M; Montufar-Solis D; Duke PJ; Cole WG
J Orthop Res; 2004 Jul; 22(4):759-67. PubMed ID: 15183431
[TBL] [Abstract][Full Text] [Related]
6. MED and PSACH COMP mutations affect chondrogenesis in chicken limb bud micromass cultures.
Roman-Blas J; Dion AS; Seghatoleslami MR; Giunta K; Oca P; Jimenez SA; Williams CJ
J Cell Physiol; 2010 Sep; 224(3):817-26. PubMed ID: 20578249
[TBL] [Abstract][Full Text] [Related]
7. Pseudoachondroplasia and multiple epiphyseal dysplasia: New etiologic developments.
Unger S; Hecht JT
Am J Med Genet; 2001; 106(4):244-50. PubMed ID: 11891674
[TBL] [Abstract][Full Text] [Related]
8. Pseudoachondroplasia and multiple epiphyseal dysplasia: mutation review, molecular interactions, and genotype to phenotype correlations.
Briggs MD; Chapman KL
Hum Mutat; 2002 May; 19(5):465-78. PubMed ID: 11968079
[TBL] [Abstract][Full Text] [Related]
9. Role of TSP-5/COMP in pseudoachondroplasia.
Posey KL; Hayes E; Haynes R; Hecht JT
Int J Biochem Cell Biol; 2004 Jun; 36(6):1005-12. PubMed ID: 15094116
[TBL] [Abstract][Full Text] [Related]
10. Novel mutations of the cartilage oligomeric matrix protein (COMP) gene in two Japanese patients with pseudoachondroplasia.
Nakayama H; Endo Y; Aota S; Sato M; Fujita T; Kikuchi S
Oncol Rep; 2003; 10(4):871-3. PubMed ID: 12792737
[TBL] [Abstract][Full Text] [Related]
11. Novel and recurrent mutations in the C-terminal domain of COMP cluster in two distinct regions and result in a spectrum of phenotypes within the pseudoachondroplasia -- multiple epiphyseal dysplasia disease group.
Kennedy J; Jackson GC; Barker FS; Nundlall S; Bella J; Wright MJ; Mortier GR; Neas K; Thompson E; Elles R; Briggs MD
Hum Mutat; 2005 Jun; 25(6):593-4. PubMed ID: 15880723
[TBL] [Abstract][Full Text] [Related]
12. Expression of PSACH-associated mutant COMP in tendon fibroblasts leads to increased apoptotic cell death irrespective of the secretory characteristics of mutant COMP.
Weirich C; Keene DR; Kirsch K; Heil M; Neumann E; Dinser R
Matrix Biol; 2007 May; 26(4):314-23. PubMed ID: 17307347
[TBL] [Abstract][Full Text] [Related]
13. Delta 469 mutation in the type 3 repeat calcium binding domain of cartilage oligomeric matrix protein (COMP) disrupts calcium binding.
Hou J; Putkey JA; Hecht JT
Cell Calcium; 2000 Jun; 27(6):309-14. PubMed ID: 11013461
[TBL] [Abstract][Full Text] [Related]
14. Reduced cell proliferation and increased apoptosis are significant pathological mechanisms in a murine model of mild pseudoachondroplasia resulting from a mutation in the C-terminal domain of COMP.
Piróg-Garcia KA; Meadows RS; Knowles L; Heinegård D; Thornton DJ; Kadler KE; Boot-Handford RP; Briggs MD
Hum Mol Genet; 2007 Sep; 16(17):2072-88. PubMed ID: 17588960
[TBL] [Abstract][Full Text] [Related]
15. Retention of cartilage oligomeric matrix protein (COMP) and cell death in redifferentiated pseudoachondroplasia chondrocytes.
Hecht JT; Montufar-Solis D; Decker G; Lawler J; Daniels K; Duke PJ
Matrix Biol; 1998 Dec; 17(8-9):625-33. PubMed ID: 9923655
[TBL] [Abstract][Full Text] [Related]
16. Mutation (D472Y) in the type 3 repeat domain of cartilage oligomeric matrix protein affects its early vesicle trafficking in endoplasmic reticulum and induces apoptosis.
Hashimoto Y; Tomiyama T; Yamano Y; Mori H
Am J Pathol; 2003 Jul; 163(1):101-10. PubMed ID: 12819015
[TBL] [Abstract][Full Text] [Related]
17. Novel and recurrent COMP (cartilage oligomeric matrix protein) mutations in pseudoachondroplasia and multiple epiphyseal dysplasia.
Ikegawa S; Ohashi H; Nishimura G; Kim KC; Sannohe A; Kimizuka M; Fukushima Y; Nagai T; Nakamura Y
Hum Genet; 1998 Dec; 103(6):633-8. PubMed ID: 9921895
[TBL] [Abstract][Full Text] [Related]
18. Novel types of COMP mutations and genotype-phenotype association in pseudoachondroplasia and multiple epiphyseal dysplasia.
Mabuchi A; Manabe N; Haga N; Kitoh H; Ikeda T; Kawaji H; Tamai K; Hamada J; Nakamura S; Brunetti-Pierri N; Kimizuka M; Takatori Y; Nakamura K; Nishimura G; Ohashi H; Ikegawa S
Hum Genet; 2003 Jan; 112(1):84-90. PubMed ID: 12483304
[TBL] [Abstract][Full Text] [Related]
19. Calreticulin, PDI, Grp94 and BiP chaperone proteins are associated with retained COMP in pseudoachondroplasia chondrocytes.
Hecht JT; Hayes E; Snuggs M; Decker G; Montufar-Solis D; Doege K; Mwalle F; Poole R; Stevens J; Duke PJ
Matrix Biol; 2001 Jul; 20(4):251-62. PubMed ID: 11470401
[TBL] [Abstract][Full Text] [Related]
20. A novel form of chondrocyte stress is triggered by a COMP mutation causing pseudoachondroplasia.
Suleman F; Gualeni B; Gregson HJ; Leighton MP; Piróg KA; Edwards S; Holden P; Boot-Handford RP; Briggs MD
Hum Mutat; 2012 Jan; 33(1):218-31. PubMed ID: 22006726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
